J. Kleintjens

Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy

E. Akpo, K. Cerri, J. Kleintjens, 2015, PharmacoEconomics.

Personalized Approach to Growth Hormone Treatment: Clinical Use of Growth Prediction Models

S. van Buuren, P. Clayton, J. Wit, 2013, Hormone Research in Paediatrics.

How Do Decision Makers in Europe Value Other Economic Evaluation Tools Than Cost-Effectiveness Analysis for Vaccines?

J. Höhne, B. Standaert, N. Demarteau, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Implications of a Data-Driven Approach to Treatment with Growth Hormone in Children with Growth Hormone Deficiency and Turner Syndrome

H. Wollmann, M. Ranke, M. Roelants, 2013, Applied Health Economics and Health Policy.

Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK

M. Palazzo, M. Sidhu, A. V. van Engen, 2009, Current medical research and opinion.

Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting

S. Simoens, E. Rietzschel, V. Thijs, 2013, PharmacoEconomics.

A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France

C. Schweitzer, A. Labbé, A. Ostawal, 2021, PloS one.

PRM43 - A COST-UTILITY ANALYSIS OF THE ISTENT INJECT TRABECULAR MICRO-BYPASS SYSTEM PLUS CATARACT SURGERY IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA IN FRANCE

J. Kleintjens, H. Falvey, G. Gicquel, 2018, Value in Health.

The economic impact and cost-effectiveness of urinary neutrophil gelatinase-associated lipocalin after cardiac surgery.

D. Chalfin, A. Shaw, J. Kleintjens, 2011, Clinical therapeutics.

Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients

G. Wan, E. Akpo, J. Kleintjens, 2015, Drugs in R&D.

Epidemiological trends for hospital admissions for acute rotavirus gastroenteritis in Belgium following the introduction of routine rotavirus vaccination and the subsequent switch from lyophilized to liquid formulation of Rotarix™

A. Vyse, T. Morel, M. Raes, 2016, Epidemiology and Infection.